Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000713783 | SCV000236410 | likely benign | not provided | 2021-02-02 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24037902, 25351510, 26220970) |
Labcorp Genetics |
RCV001079164 | SCV000287958 | likely benign | Hypertrophic cardiomyopathy 25; Primary familial hypertrophic cardiomyopathy | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000713783 | SCV000336815 | uncertain significance | not provided | 2017-12-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617934 | SCV000739918 | likely benign | Cardiovascular phenotype | 2018-05-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000713783 | SCV000844414 | uncertain significance | not provided | 2017-10-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769481 | SCV000900876 | uncertain significance | Cardiomyopathy | 2015-11-03 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV001256811 | SCV001433266 | uncertain significance | Hypertrophic cardiomyopathy 1 | 2019-12-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003927715 | SCV004746625 | likely benign | TCAP-related disorder | 2022-10-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |